AdaptHealth (NASDAQ:AHCO) Upgraded to “Buy” at Jefferies Financial Group

Jefferies Financial Group upgraded shares of AdaptHealth (NASDAQ:AHCO) from a hold rating to a buy rating in a report published on Tuesday, MarketBeat Ratings reports. Jefferies Financial Group currently has $13.00 price target on the stock, up from their previous price target of $11.00.

A number of other research analysts also recently issued reports on the company. Canaccord Genuity Group upped their price target on AdaptHealth from $14.00 to $16.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Wall Street Zen upgraded AdaptHealth from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Truist Financial boosted their target price on AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Monday, April 13th. Weiss Ratings restated a “sell (d)” rating on shares of AdaptHealth in a research note on Friday, May 22nd. Finally, Royal Bank Of Canada boosted their price objective on shares of AdaptHealth from $13.00 to $15.00 and gave the company an “outperform” rating in a report on Monday, May 11th. Seven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, AdaptHealth currently has an average rating of “Moderate Buy” and an average price target of $14.14.

AdaptHealth Stock Performance

AHCO stock opened at $11.21 on Tuesday. The stock’s 50 day simple moving average is $10.24 and its 200 day simple moving average is $10.64. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 1.21. AdaptHealth has a 12-month low of $8.51 and a 12-month high of $13.43. The stock has a market capitalization of $1.52 billion, a PE ratio of -18.08, a price-to-earnings-growth ratio of 0.56 and a beta of 1.45.

Insider Buying and Selling

In related news, insider Russell E. Schuster III sold 11,275 shares of the firm’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $10.06, for a total value of $113,426.50. Following the transaction, the insider directly owned 136,538 shares of the company’s stock, valued at approximately $1,373,572.28. This trade represents a 7.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.95% of the company’s stock.

Hedge Funds Weigh In On AdaptHealth

Large investors have recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of AdaptHealth by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 60,495 shares of the company’s stock valued at $656,000 after buying an additional 2,564 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in AdaptHealth by 32.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 571,232 shares of the company’s stock worth $6,192,000 after acquiring an additional 139,828 shares during the last quarter. Woodline Partners LP bought a new stake in AdaptHealth in the first quarter worth $2,851,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of AdaptHealth by 18.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 233,780 shares of the company’s stock worth $2,534,000 after buying an additional 35,879 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in AdaptHealth by 1.3% during the second quarter. JPMorgan Chase & Co. now owns 211,769 shares of the company’s stock worth $1,997,000 after acquiring an additional 2,718 shares during the last quarter. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.